1] Department of Biology, Technische Universität Darmstadt, 64287 Darmstadt, Germany [2].
Nat Commun. 2013;4:2660. doi: 10.1038/ncomms3660.
Protein-protein interactions are the basis of all processes in living cells, but most studies of these interactions rely on biochemical in vitro assays. Here we present a simple and versatile fluorescent-three-hybrid (F3H) strategy to visualize and target protein-protein interactions. A high-affinity nanobody anchors a GFP-fusion protein of interest at a defined cellular structure and the enrichment of red-labelled interacting proteins is measured at these sites. With this approach, we visualize the p53-HDM2 interaction in living cells and directly monitor the disruption of this interaction by Nutlin 3, a drug developed to boost p53 activity in cancer therapy. We further use this approach to develop a cell-permeable vector that releases a highly specific peptide disrupting the p53 and HDM2 interaction. The availability of multiple anchor sites and the simple optical readout of this nanobody-based capture assay enable systematic and versatile analyses of protein-protein interactions in practically any cell type and species.
蛋白质-蛋白质相互作用是所有活细胞过程的基础,但这些相互作用的大多数研究都依赖于生化体外测定。在这里,我们提出了一种简单而通用的荧光三联体(F3H)策略,用于可视化和靶向蛋白质-蛋白质相互作用。高亲和力纳米抗体将感兴趣的 GFP 融合蛋白锚定在特定的细胞结构上,并在这些位置测量红色标记的相互作用蛋白的富集情况。通过这种方法,我们在活细胞中可视化了 p53-HDM2 相互作用,并直接监测了 Nutlin 3(一种旨在提高癌症治疗中 p53 活性的药物)对这种相互作用的破坏。我们进一步利用这种方法开发了一种细胞通透性载体,它释放一种高度特异性的肽,破坏 p53 和 HDM2 相互作用。这种基于纳米抗体的捕获测定法具有多个锚定位点和简单的光学读取功能,可用于系统地、灵活地分析实际上任何细胞类型和物种中的蛋白质-蛋白质相互作用。